Stroke Diagnostics Market

Global Stroke Diagnostics Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2022-2028- Increasing Prevalence of Stroke,  and rising number of tobacco users are major factors anticipated to drive the growth of the global stroke diagnostics market for the forecast period.

The Global Stroke Diagnostics Market is valued at USD 2.20 Billion in 2021 and is expected to reach USD 7.89 Billion by 2028 with a CAGR of 19.25% over the forecast period.

Scope–

A stroke is caused by an obstruction of blood flow within the brain. The number of tests done to confirm the diagnosis and determine the cause of the stroke is called a diagnostic stroke. Ischemic and hemorrhagic are the two types of strokes. The diagnostic tests examine a combination of data including tests, symptoms, and medical history to identify the type of stroke and, more specifically, which area of the brain is affected. The tests used to diagnose a stroke such as blood tests, swallow tests and blood pressure, as well as brain scans should also be done to determine the severity of the stroke. The treatment of stroke generally requires different medicines, though some people may also need surgery.

The covid-19 pandemic has shown negative impact on global stroke diagnostics market.  The increasing number of patients infected with COVID-19 caused enormous efforts to reorganize medical assistance and several diseases, including stroke. Access to acute stroke diagnostics and time‐dependent therapies was delayed because of reduced capacity of emergency services due to the burden of patients with COVID‐19. Additionally, COVID-19 may increase the risk of stroke in particular groups. The presence of the pandemic may also boost the risk of difficulties and severe disease in stroke survivors, regardless of the cause of their stroke.

The global stroke diagnostics market is segmented into diagnostics, end users, application region & country level. Based on diagnostics, the global stroke diagnostics is segmented into computed tomography (CT) scan, magnetic resonance imaging (MRI), carotid ultrasound, cerebral angiography, nuclear imaging, and others. On the basis of application, the market is segmented into ischemic stroke and haemorrhagic stroke. Based on end users, the global stroke diagnostics market is segmented into clinics and hospital,

The regions covered in global stroke diagnostics market report are North America, Europe, Asia-Pacific, Latin America, and Rest of the World. Based on country level, the market of global stroke diagnostics market is subdivided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, India, Japan, Southeast Asia, Middle East Asia (UAE, Egypt, Saudi Arabia) GCC, Africa, etc.

Key Players-

Some of the key players for global stroke diagnostics market are -

• Analogic Corporation
• Siemens
• Koninklijke Philips N.V.
• Canon Inc.
• FONAR Corp.
• General Electric Company
• Shenzhen Mindray Bio-Medical Electronics Co.Ltd.
• FUJIFILM Holdings Corporation
• Canon Inc.
• BPL Medical Technologies
• ALPINION MEDICAL SYSTEMS Co.Ltd
• Analogic Corporation
• SAMSUNG
• Shimadzu Corporation
• SIUI
• others

Segmentation: -

By Diagnostics: -

• Computed Tomography (CT) Scan
• Magnetic Resonance Imaging (MRI)
• Carotid Ultrasound
• Cerebral Angiography
• Nuclear Imaging
• Others

By Application: -

• Ischemic Stroke
• Haemorrhagic Stroke

By End Users: -

• Clinics
• Hospital

By Regional & Country Level:

• North America

  • U.S.
  • Canada

• Europe

  • U.K.
  • France
  • Germany
  • Italy

• Asia Pacific

  • China
  • Japan
  • India
  • Southeast Asia

• Latin America

  • Brazil
  • Mexico

• Middle East and Africa

  • GCC
  • Africa
  • Rest of Middle East and Africa

Market Dynamics-

Increasing Prevalence of Stroke, rising technological advanced products launches for stroke diagnostic, and rising number of tobacco users are major factors anticipated to drive the growth of the global stroke diagnostics market for the forecast period.

One of the major factors driving the growth of the global stroke diagnostics market is the increasing prevalence of stroke. In the recent year increasing changes in lifestyle and medical complications are some of the factors that majorly affected on the human body similarly on human population. Several people are have their busy lifestyle and it boosting the Being overweight or obese, Physical inactivity, Heavy or binge drinking, Use of illegal drugs such as cocaine and methamphetamine habits thus it affecting on the health. For example, as per the Stroke Awareness Foundation in the United States, about 795,000 people suffer a stroke each year. Thus, the increasing prevalence of stroke is the primary factor driving the growth of global stroke diagnostics market for the forecast period. In addition, increasing technological advanced product launches is boosting the market growth. Technology and future advances in stroke diagnostics are fueling the market growth. For example, Vscan, a pocket-sized, wireless ultrasound scanner launched by the General Electric company in March 2021.

Moreover, rising number of tobaccos consumers is another factor driving the market growth of the global stroke diagnostic. The tobacco use is a major preventable risk factor of strokes. Hence the rising number of tobacco user will increase the number of global stroke diagnostics market. Additionally, regular smoking doubles the risk of stroke in men. Chemical moieties produced by burning tobacco are probably the most important contributors to smokers’ excess risk of atherothrombotic disease, including stroke. For example, each year, secondhand smoke exposure causes more than 8,000 deaths from stroke. For instance, as per CDC in 2021, an estimated 34.0% of high school students reported using Tobacco products. Thus, rising number of tobaccos consumers also boosting growth of the stroke diagnostics market.

However, the high cost of treatments restraining the market growth. In spite of that, development of new technology is providing opportunities for the global stroke diagnostics market for the forecast period.

The North America Dominating Global Stroke Diagnostics Market

North America is dominating the global stroke diagnostics market due to increasing number of patients with ischemic stroke, highly developed healthcare infrastructure, research, and development of novel stroke diagnostic treatments.  Additionally, changing lifestyle, food consumption and rising smoking habits may supplementing the incidence of strokes. For instance, the incidence of stroke in U.S was 3.5% in 2020 and it was anticipated to increase to 3.89% by 2030 by the American Heart Association. Thus, all factors boosting growth of the stroke diagnostics market in the North America region.

Asia Pacific is the second largest market for the growth of the stroke diagnostics market due to growing elderly population, rising R&D activities, and developing healthcare framework in the region. For instance, India’s elderly population will rise from its current 60 million to over 227 million by 2050, as per the World Health Organization. Hence, the risk of stroke is greater in the geriatric population and increasing population of geriatric people will further boost the global stroke diagnostic market in the Asia-Pacific region.

Recent Development-

Ground-breaking AI stroke Diagnostic Software Framework Launched

8^th March 2022; Artificial intelligence software that supports stroke treatment was launched by NHS Shared Business Services (NHS SBS) for the analysis of images for the detection of ischaemic or haemorrhagic strokes.

XBiotech Launched Novel Candidate Therapy for Stroke

28^th October 2021; a randomized clinical study to test its new True Human antibody therapy for reducing brain injury after stroke was launched by XBiotech. The study conducted across the United States at medical centers that deliver advanced stroke care.

Report Analysis	Details
Historical data	2018 - 2021
Forecast Period	2021 - 2028
Market Size in 2021:	USD 2.20 Billion
Base year considered	2021
Forecast Period CAGR %:	19.25%
Market Size Expected in 2028:	USD 7.89 Billion
Tables, Charts & Figures:	175
Pages	200
Companies	Analogic Corporation, Siemens, Koninklijke Philips N.V. Canon Inc. FONAR Corp., General Electric Company, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., FUJIFILM Holdings Corporation, Canon Inc. BPL Medical Technologies, ALPINION MEDICAL SYSTEMS Co., Ltd, Analogic Corporation, SAMSUNG, Shimadzu Corporation, SIUI and others.
Segments Covered	By Diagnostics, By Application, By End Users
Regional Analysis	North America, U.S., Mexico, Canada, Europe, UK, France, Germany, Italy, Asia Pacific, China, Japan, India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of the Middle East and Africa

Key Benefits-

• Global Stroke Diagnostics Market report covers in-depth historical and forecast analysis.
• Global Stroke Diagnostics Market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market Opportunities, Competitive Analysis, Regional and Country Level.
• Global Stroke Diagnostics Market report helps to identify opportunities in marketplace.
• Global Stroke Diagnostics Market report covers extensive analysis of emerging trends and competitive landscape.